Climb Bio, Inc. (CLYM) Tops Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts CLYM Hot Sheet
Join SI Premium – FREE
Climb Bio, Inc. (NASDAQ: CLYM) reported Q2 EPS of ($0.18), $0.03 better than the analyst estimate of ($0.21).
For earnings history and earnings-related data on Climb Bio, Inc. (CLYM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westport Fuel Systems (WPRT) Misses Q2 EPS by 64c
- Erasca, Inc. (ERAS) Misses Q2 EPS by 3c
- Pliant Therapeutics, Inc. (PLRX) Misses Q2 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
